Viridian Therapeutics, Inc.\DE (VRDN) Debt Ratio (2013 - 2026)
Viridian Therapeutics, Inc.\DE's Debt Ratio came in at 0.10 for Q2 2026, up 190.1% from 0.04 a year earlier and up 62.0% from the prior quarter.
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Debt Ratio (2013 - 2026) Analysis & Trends
For FY2025, Viridian Therapeutics, Inc.\DE's Debt Ratio was 0.06, up 100.3% from FY2024.
- Going back by year, Debt Ratio was 0.03 in FY2024 (-32.7%) and 0.04 in FY2023.
- The Q2 2026 figure represents the highest quarterly Debt Ratio since Q3 2020.
- Year-over-year, Debt Ratio has increased for five consecutive quarters, with growth averaging 66.7% over the last six quarters.
- Business Quant data shows VRDN's Debt Ratio at 0.06 (Q1 2026), 0.06 (Q4 2025) and 0.04 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 0.24 |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 0.31 |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 0.00 |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 0.60 |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 0.53 |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Viridian Therapeutics, Inc.\DE | 2.33 Bn | 2.33 Bn | - | 0.10 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.10 |
| Mar 31, 2026 | 0.06 |
| Dec 31, 2025 | 0.06 |
| Sep 30, 2025 | 0.04 |
| Jun 30, 2025 | 0.04 |
| Mar 31, 2025 | 0.03 |
| Dec 31, 2024 | 0.03 |
| Sep 30, 2024 | 0.03 |
| Jun 30, 2024 | 0.03 |
| Dec 31, 2023 | 0.04 |
| Sep 30, 2020 | 0.27 |
| Jun 30, 2020 | 0.26 |
| Mar 31, 2020 | 0.19 |
| Dec 31, 2019 | 0.27 |
| Sep 30, 2019 | 0.24 |
| Jun 30, 2019 | 0.21 |
| Mar 31, 2019 | 0.19 |
| Dec 31, 2018 | 0.16 |
| Sep 30, 2018 | 0.13 |
| Jun 30, 2018 | 0.12 |
API Access
Viridian Therapeutics, Inc.\DE Debt Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=debt-ratio&ticker=VRDN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "debt-ratio", "ticker": "VRDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=debt-ratio&ticker=VRDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();